| 000 | 01661 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515171404.0 | ||
| 264 | 0 | _c20090624 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.108.822205 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeddon, Michael | |
| 245 | 0 | 0 |
_aEffects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. _h[electronic resource] |
| 260 |
_bCirculation _cMay 2009 |
||
| 300 |
_a2656-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCitrulline _xadministration & dosage |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Vessels _xphysiology |
| 650 | 0 | 4 |
_aForearm _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xphysiology |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xphysiology |
| 650 | 0 | 4 |
_aThiourea _xadministration & dosage |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMelikian, Narbeh | |
| 700 | 1 | _aDworakowski, Rafal | |
| 700 | 1 | _aShabeeh, Husain | |
| 700 | 1 | _aJiang, Benyu | |
| 700 | 1 | _aByrne, Jonathan | |
| 700 | 1 | _aCasadei, Barbara | |
| 700 | 1 | _aChowienczyk, Philip | |
| 700 | 1 | _aShah, Ajay M | |
| 773 | 0 |
_tCirculation _gvol. 119 _gno. 20 _gp. 2656-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.108.822205 _zAvailable from publisher's website |
| 999 |
_c18861626 _d18861626 |
||